BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3096881)

  • 1. Cyclosporine inhibits the expression of receptors for interleukin 2 and transferrin on mitogen-activated human T lymphocytes.
    Prince HE; John JK
    Immunol Invest; 1986 Aug; 15(5):463-72. PubMed ID: 3096881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
    Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
    J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique pattern of interleukin 2 receptor expression by lymphocytes in response to anti-Leu 4 monoclonal antibody: relationship to monocyte accessory cell function.
    Prince HE; John JK
    Diagn Immunol; 1986; 4(5):241-6. PubMed ID: 3098490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early activation marker expression to detect impaired proliferative responses to pokeweed mitogen and tetanus toxoid: studies in patients with AIDS and related disorders.
    Prince HE; John JK
    Diagn Immunol; 1986; 4(6):306-11. PubMed ID: 3102150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
    Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
    Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Scand J Immunol; 1990 Mar; 31(3):297-304. PubMed ID: 1690915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
    Redelman D
    Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
    Lillehoj HS; Malek TR; Shevach EM
    J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.
    Reed JC; Alpers JD; Nowell PC; Hoover RG
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3982-6. PubMed ID: 3012540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
    Stohl W; Linker-Israeli M
    Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effect of cyclosporine on the nuclear proliferative response to a variety of T cell activators.
    Citterio F; Kahan BD
    Transplantation; 1989 Feb; 47(2):334-8. PubMed ID: 2521963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired expression of interleukin-2 receptor (IL2R) in the immunosuppressed burned patient: reversal by exogenous IL2.
    Teodorczyk-Injeyan JA; Sparkes BG; Mills GB; Falk RE; Peters WJ
    J Trauma; 1987 Feb; 27(2):180-7. PubMed ID: 3102753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
    Bjorndahl JM; Sung SS; Hansen JA; Fu SM
    Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
    Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
    Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte activation by OKT3: cyclosporine sensitivity and synergism with phorbol ester.
    Kay JE; Benzie CR
    Immunology; 1986 Feb; 57(2):195-9. PubMed ID: 3485075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level.
    Pelosi-Testa E; Samoggia P; Giannella G; Montesoro E; Caravita T; Salvo G; Camagna A; Isacchi G; Testa U; Peschle C
    Immunology; 1988 Jun; 64(2):273-9. PubMed ID: 3134296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2.
    Neckers LM; Cossman J
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3494-8. PubMed ID: 6304712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
    Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
    Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclosporin A on the anti-CD3 antibody- and concanavalin A-induced activation and membrane potential of human T lymphocytes.
    Gergely P; Aszalos A
    Immunopharmacology; 1990; 20(3):191-9. PubMed ID: 2149721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.